filmov
tv
Dionysus Health: Early Detection of Postpartum Depression for Better Outcomes
Показать описание
Watch this presentation, given by One Mind Accelerator alumni Andrea Cubitt, at the 2024 Science & Innovation Symposium as part of the 30th One Mind Music Festival for Brain Health, held in Napa County, CA on September 7, 2024.
Andrea Cubitt, PhD, is the Co-Founder and CEO of Dionysus Digital Health. She brings a proven track record of success building high value new companies. After completing a post-doctoral fellowship at Cornell Medical Center, Andrea started her professional career at the Howard Hughes Medical Institute at the University of California, San Diego where her work formed part of the research recognized by the Nobel Prize for Chemistry awarded to Roger Tsien in 2008. She left Academia in 1996 to commercialize this technology at Aurora Biosciences Corporation, which was subsequently acquired by Vertex Pharmaceuticals. In 2005, she co-founded AnaptysBio, INC, (IPO 2017) where she was instrumental in the development of the initial business plan and intellectual property strategies. She has spent much of her career bringing groundbreaking new technologies from bench research to commercialization with multiple successful exits.
ABOUT DIONYSUS:
Dionysus, a 2024 One Mind Accelerator Company, is developing the first clinically validated epigenetic tests to diagnose hormonal depressions like postpartum depression, PMS, and menopause in women, and to offer precision medical insights to enable the most effective treatments.
ABOUT ONE MIND
One Mind is the leading brain health nonprofit committed to healing the lives of people impacted by brain illness and injury through global, collaborative action. One Mind catalyzes visionary change through science, business, and media to dismantle stigma and discrimination and transform the world’s mental health. One Mind accelerates collaborative research and advocacy to enable all individuals facing brain health challenges to build healthy, productive lives.
FOLLOW ONE MIND
#MentalHealth #Science #BrainHealthForAll #OneMind
Andrea Cubitt, PhD, is the Co-Founder and CEO of Dionysus Digital Health. She brings a proven track record of success building high value new companies. After completing a post-doctoral fellowship at Cornell Medical Center, Andrea started her professional career at the Howard Hughes Medical Institute at the University of California, San Diego where her work formed part of the research recognized by the Nobel Prize for Chemistry awarded to Roger Tsien in 2008. She left Academia in 1996 to commercialize this technology at Aurora Biosciences Corporation, which was subsequently acquired by Vertex Pharmaceuticals. In 2005, she co-founded AnaptysBio, INC, (IPO 2017) where she was instrumental in the development of the initial business plan and intellectual property strategies. She has spent much of her career bringing groundbreaking new technologies from bench research to commercialization with multiple successful exits.
ABOUT DIONYSUS:
Dionysus, a 2024 One Mind Accelerator Company, is developing the first clinically validated epigenetic tests to diagnose hormonal depressions like postpartum depression, PMS, and menopause in women, and to offer precision medical insights to enable the most effective treatments.
ABOUT ONE MIND
One Mind is the leading brain health nonprofit committed to healing the lives of people impacted by brain illness and injury through global, collaborative action. One Mind catalyzes visionary change through science, business, and media to dismantle stigma and discrimination and transform the world’s mental health. One Mind accelerates collaborative research and advocacy to enable all individuals facing brain health challenges to build healthy, productive lives.
FOLLOW ONE MIND
#MentalHealth #Science #BrainHealthForAll #OneMind
0:08:35
0:18:54
0:04:09
0:04:56
0:16:18
0:00:07
0:59:05
0:00:37
0:00:14
0:00:25
0:17:41
0:16:30
0:13:21
0:03:02
0:04:21
0:03:33
0:31:10
0:01:12
1:00:15
0:15:37
1:00:35
0:47:39
0:58:32
0:24:32